These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7539780

  • 1. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
    Kalechman Y, Shani A, Albeck M, Sredni B.
    Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
    [Abstract] [Full Text] [Related]

  • 2. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B.
    Blood; 1995 Mar 15; 85(6):1555-61. PubMed ID: 7888674
    [Abstract] [Full Text] [Related]

  • 3. Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101.
    Kalechman Y, Shani A, Albeck M, Sotnik Barkai I, Sredni B.
    Radiat Res; 1993 Nov 15; 136(2):197-204. PubMed ID: 8248476
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of radioprotection conferred by the immunomodulator AS101.
    Kalechman Y, Gafter U, Barkai IS, Albeck M, Sredni B.
    Exp Hematol; 1993 Jan 15; 21(1):150-5. PubMed ID: 8417951
    [Abstract] [Full Text] [Related]

  • 5. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.
    Sredni B, Albeck M, Kazimirsky G, Shalit F.
    Int J Immunopharmacol; 1992 May 15; 14(4):613-9. PubMed ID: 1521929
    [Abstract] [Full Text] [Related]

  • 6. Radioprotective effects of the immunomodulator AS101.
    Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Seghal SN, Sredni B.
    J Immunol; 1990 Sep 01; 145(5):1512-7. PubMed ID: 2384668
    [Abstract] [Full Text] [Related]

  • 7. The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment.
    Kalechman Y, Sotnik-Barkai I, Albeck M, Sredni B.
    Exp Hematol; 1992 Dec 01; 20(11):1302-8. PubMed ID: 1493859
    [Abstract] [Full Text] [Related]

  • 8. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y, Gafter U, Gal R, Rushkin G, Yan D, Albeck M, Sredni B.
    J Immunol; 2002 Jul 01; 169(1):384-92. PubMed ID: 12077268
    [Abstract] [Full Text] [Related]

  • 9. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y, Rushkin G, Nerubay J, Albeck M, Sredni B.
    Exp Hematol; 1995 Dec 01; 23(13):1358-66. PubMed ID: 7498364
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective and restorative role of AS101 in combination with chemotherapy.
    Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Horwith G, Kirsch T, Maida B, Sehgal SN, Sredni B.
    Cancer Res; 1991 Mar 01; 51(5):1499-503. PubMed ID: 1997189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
    Kalechman Y, Sotnik-Barkai I, Albeck M, Sredni B.
    Cancer Res; 1993 Apr 15; 53(8):1838-44. PubMed ID: 8467503
    [Abstract] [Full Text] [Related]

  • 19. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
    Kalechman Y, Shani A, Sotnik-Barkai I, Albeck M, Sredni B.
    Cancer Res; 1993 Dec 15; 53(24):5962-9. PubMed ID: 8261410
    [Abstract] [Full Text] [Related]

  • 20. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
    Rosenblatt-Bin H, Kalechman Y, Vonsover A, Xu RH, Da JP, Shalit F, Huberman M, Klein A, Strassmann G, Albeck M, Sredni B.
    Cell Immunol; 1998 Feb 25; 184(1):12-25. PubMed ID: 9626331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.